223 related articles for article (PubMed ID: 37570897)
1. The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.
Basiak M; Hachula M; Kosowski M; Machnik G; Maliglowka M; Dziubinska-Basiak M; Krysiak R; Okopien B
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570897
[TBL] [Abstract][Full Text] [Related]
2. Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
Kosowski M; Basiak M; Hachuła M; Okopień B
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888688
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
Strobescu-Ciobanu C; Giuşcă SE; Căruntu ID; Amălinei C; Rusu A; Cojocaru E; Popa RF; Lupaşcu CD
Rom J Morphol Embryol; 2020; 61(3):793-801. PubMed ID: 33817720
[TBL] [Abstract][Full Text] [Related]
4. Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia-A Pilot Study.
Kosowski M; Basiak M; Hachuła M; Okopień B
Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743980
[TBL] [Abstract][Full Text] [Related]
5. Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
Basiak M; Kosowski M; Hachula M; Okopien B
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890100
[TBL] [Abstract][Full Text] [Related]
6. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
7. Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab.
Sun J; Lepor NE; Cantón G; Contreras L; Hippe DS; Isquith DA; Balu N; Kedan I; Simonini AA; Yuan C; Zhao XQ; Hatsukami TS
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1415-1422. PubMed ID: 33392875
[TBL] [Abstract][Full Text] [Related]
8. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis.
Asanuma YF; Shimada Y; Kouzu N; Yokota K; Nakajima K; Sato K; Akiyama Y; Isozaki M; Mikami AS; Kobayashi H; Mimura T
Mod Rheumatol; 2013 Mar; 23(2):269-75. PubMed ID: 22584471
[TBL] [Abstract][Full Text] [Related]
9. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
[TBL] [Abstract][Full Text] [Related]
10. Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study.
Lepor NE; Sun J; Canton G; Contreras L; Hippe DS; Isquith DA; Balu N; Kedan I; Simonini AA; Yuan C; Hatsukami TS; Zhao XQ
Atherosclerosis; 2021 Jun; 327():31-38. PubMed ID: 34038761
[TBL] [Abstract][Full Text] [Related]
11. PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging.
Huang YC; Chang CH; Tsai YH; Weng HH; Lin LC; Lee JD
BMJ Open; 2022 Apr; 12(4):e060068. PubMed ID: 35487727
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of ezetimibe, evolocumab, and alirocumab on plaque burden and lipid content as assessed by intravascular ultrasound: A PRISMA-compliant meta-analysis.
Liang D; Li C; Tu Y; Li Z; Zhang M
Medicine (Baltimore); 2022 Oct; 101(41):e31199. PubMed ID: 36254013
[TBL] [Abstract][Full Text] [Related]
13. Advanced ultrasound methods in assessment of carotid plaque instability: a prospective multimodal study.
Zamani M; Skagen K; Scott H; Russell D; Skjelland M
BMC Neurol; 2020 Jan; 20(1):39. PubMed ID: 31996153
[TBL] [Abstract][Full Text] [Related]
14. N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients.
Wolak T; Sion-Vardi N; Novack V; Greenberg G; Szendro G; Tarnovscki T; Nov O; Shelef I; Paran E; Rudich A
Am J Hypertens; 2013 Mar; 26(3):326-33. PubMed ID: 23382482
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability.
Straface G; Biscetti F; Pitocco D; Bertoletti G; Misuraca M; Vincenzoni C; Snider F; Arena V; Stigliano E; Angelini F; Iuliano L; Boccia S; de Waure C; Giacchi F; Ghirlanda G; Flex A
Stroke; 2011 Nov; 42(11):3022-8. PubMed ID: 21903966
[TBL] [Abstract][Full Text] [Related]
16. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
[TBL] [Abstract][Full Text] [Related]
17. Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability.
Qian YN; Luo YT; Duan HX; Feng LQ; Bi Q; Wang YJ; Yan XY
CNS Neurosci Ther; 2014 May; 20(5):438-45. PubMed ID: 24612514
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker.
Magenta A; Sileno S; D'Agostino M; Persiani F; Beji S; Paolini A; Camilli D; Platone A; Capogrossi MC; Furgiuele S
Clin Sci (Lond); 2018 Nov; 132(22):2423-2436. PubMed ID: 30389857
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Li F; Sun XJ; Xie H; Wang Y; Zhang YK
Shanghai Kou Qiang Yi Xue; 2015 Oct; 24(5):589-93. PubMed ID: 26598194
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation.
Karagiannis AD; Liu M; Toth PP; Zhao S; Agrawal DK; Libby P; Chatzizisis YS
Curr Atheroscler Rep; 2018 Mar; 20(4):20. PubMed ID: 29525934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
